Compare KRYS & ATR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KRYS | ATR |
|---|---|---|
| Founded | 2015 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Plastic Products |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.6B | 8.5B |
| IPO Year | 2017 | 1995 |
| Metric | KRYS | ATR |
|---|---|---|
| Price | $345.86 | $134.80 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 4 |
| Target Price | ★ $297.60 | $170.25 |
| AVG Volume (30 Days) | ★ 508.3K | 457.8K |
| Earning Date | 05-04-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 1.56% |
| EPS Growth | ★ 128.00 | 6.51 |
| EPS | ★ 3.62 | 2.48 |
| Revenue | $389,130,000.00 | ★ $3,777,181,000.00 |
| Revenue This Year | $38.74 | $5.18 |
| Revenue Next Year | $32.53 | $4.98 |
| P/E Ratio | $93.10 | ★ $53.61 |
| Revenue Growth | ★ 33.94 | 5.42 |
| 52 Week Low | $143.09 | $103.23 |
| 52 Week High | $382.54 | $146.24 |
| Indicator | KRYS | ATR |
|---|---|---|
| Relative Strength Index (RSI) | 54.09 | 57.48 |
| Support Level | $253.89 | $128.74 |
| Resistance Level | $382.33 | $136.65 |
| Average True Range (ATR) | 10.03 | 2.59 |
| MACD | 1.62 | -0.53 |
| Stochastic Oscillator | 98.36 | 52.35 |
Krystal Biotech Inc is an integrated, commercial-stage biotechnology company focused on the discovery, development, manufacturing, and commercialization of genetic medicines to treat diseases with high unmet medical needs. The company uses its patented HSV-1-based gene therapy platform to create vectors that deliver therapeutic transgenes to target cells. It possesses exclusive rights to develop, manufacture, and commercialize VYJUVEK internationally. The company operates as one operating segment focused on pharmaceutical products and manufactures, markets, and sells VYJUVEK in the United States and markets and sells VYJUVEK in the European Union, and Japan.
Headquartered in Crystal Lake, Illinois, AptarGroup is a leading global supplier of dispensing systems such as aerosol valves, pumps, closures, and elastomer packaging components to the consumer goods and pharmaceutical markets. Its sales are primarily from Europe (49% of sales) and the United States (28%), with China contributing 5% and other countries contributing 17%. It operates three business segments, Pharma, Beauty, and Closures. Pharma generates over two thirds of group profits.